Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 95%
filed 2026-06-23
Item 5.07
This Item 5.07 discloses the results of a Special Meeting of Stockholders held on June 23, 2026, where shareholders voted on multiple material matters: election of a Class I director (Lauren Chung), approval of a reverse stock split amendment (1-for-5 to 1-for-200 ratio), approval of convertible preferred stock issuance to Bio Insights LLC for asset acquisition, approval of potential dilutive issuance upon conversion of a promissory note to NorthView Sponsor I LLC, and amendment to the 2025 Equity and Incentive Plan. The filing presents detailed vote tallies for each proposal, which is the core disclosure required by Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Alto Ingredients held its 2026 Annual Meeting of Stockholders on June 23, 2026, with voting results on four proposals: election of five directors (Gilbert E. Nathan, Bryon T. McGregor, Dianne S. Nury, Maria G. Gray, and Alan R. Tank), say-on-pay approval of 2025 named executive officer compensation, approval of the 2026 Omnibus Incentive Plan, and ratification of RSM US LLP as independent auditor.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 75%
filed 2026-06-23
This is a proxy statement and notice for Vale's Extraordinary General Meeting scheduled for July 22, 2026, which will address three items: (1) removal of Daniel André Stieler from the Board of Directors, (2) election of a replacement director, and (3) election of a new Chairman. While the document itself is a notice and proxy solicitation rather than a report of results, it discloses material governance matters—specifically the removal of a board member and election of new leadership—that constitute shareholder voting events. The Board's message emphasizes governance enhancement and board strengthening, indicating these are material governance changes. However, since this is a prospective notice rather than a results disclosure, `shareholder_vote_results` is the closest fit, though the actual vote results are not yet reported.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Monopar's Annual Meeting held on June 22, 2026. The filing presents voting outcomes for four proposals: election of six directors (all elected), advisory approval of NEO compensation, approval of the 2026 Stock Incentive Plan, and ratification of BPM LLP as independent auditor. All proposals passed with substantial majorities, making this a standard shareholder vote results disclosure that is material to investors' understanding of governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Results of the June 18, 2026 Annual Meeting of Stockholders, including election of nine directors, approval of a Certificate of Incorporation amendment to increase authorized shares from 100 million to 125 million, ratification of PricewaterhouseCoopers LLP as independent auditors, and advisory approval of named executive officer compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Sky Harbour Group Corp held its Annual Meeting of Stockholders on June 18, 2026, with voting results disclosed for five proposals: election of seven directors, amendment to the 2022 Incentive Award Plan increasing the share reserve by 1,500,000 shares of Class A Common Stock, ratification of EisnerAmper LLP as independent auditor, say-on-pay advisory vote, and frequency of future advisory votes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Shareholders approved six proposals at the Annual Meeting: election of seven directors, approval of Amended and Restated Articles of Association, amendments to the Compensation Policy and 2017 Equity Incentive Plan, an advisory vote on named executive officer compensation, and engagement of PricewaterhouseCoopers LLP as independent auditor. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Stockholders voted at the Annual Meeting of Stockholders held on June 22, 2026, approving five proposals: election of three Class III directors (Marina Bozilenko, Joseph Todisco, Mark Wan), ratification of BPM LLP as independent auditor, advisory approval of named executive officer compensation, approval of amendments to the 2020 Equity Incentive Plan, and approval of amendments to the 2011 Employee Stock Purchase Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of an Annual Meeting of Stockholders held on June 23, 2026. The filing presents final voting tallies for three proposals: election of seven directors, ratification of the independent auditor (SR CPA & Co.), and advisory ratification of named executive officer compensation. The detailed vote counts (For, Against, Withheld, Abstentions, Broker Non-Votes) are the hallmark of shareholder vote result disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 disclosure reports the results of the Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes on three proposals: election of three Class I Directors (Junli He, James Shmerling, and Mao Zhang), ratification of CBIZ CPAs P.C. as independent auditor, and non-binding advisory approval of named executive officer compensation. The filing explicitly presents vote tallies (votes for, against, withheld, and broker non-votes) for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Stockholders voted at the Annual Meeting on four proposals: election of three Class III directors (Friesner, Kapeller-Libermann, Sender), advisory vote on executive compensation, approval of a 2022 Equity Incentive Plan amendment increasing the share reserve by 3,000,000 shares, and ratification of KPMG LLP as independent auditor. Detailed voting results including FOR, AGAINST, ABSTAINING, and BROKER NON-VOTES tallies were disclosed for each proposal.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 92%
filed 2026-06-23
The 6-K discloses results of an Extraordinary General Meeting held on June 22, 2026, where shareholders approved two resolutions: (1) re-designation of 1,000,000 issued preferred shares as Series A preferred shares and authorization of 49,000,000 additional preferred shares with rights to be determined by Directors, and (2) adoption of a Third Amended and Restated Memorandum and Articles of Association. This is a classic shareholder vote result disclosure. The Share Redesignation and Share Capital Changes are material to investors as they alter the company's authorized capital structure and preferred share terms.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This 8-K Item 5.07 discloses the final voting results from GeneDx Holdings Corp.'s Annual Meeting of Stockholders held on June 18, 2026. The filing presents detailed tabulations of votes cast on four proposals: election of a Class II director (Katherine Stueland), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on the frequency of future compensation votes. All proposals were approved. This is a standard shareholder vote results disclosure required under Item 5.07.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-23
EX-99.1
This exhibit discloses the results of Klarna Group plc's 2026 Annual General Meeting held on 22 June 2026, with detailed voting tallies for all 12 resolutions including re-appointment of directors (Niclas Neglén, Andrew Reed, Mateusz Staniszewski, Markus Villig), re-appointment of auditors (Ernst & Young LLP), and approval of remuneration policies. All resolutions passed at or above 99% of votes cast, representing shareholder governance decisions that are material to investors' assessment of board composition and auditor continuity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This 8-K Item 5.07 discloses the final voting results from Inuvo's June 18, 2026 Annual Meeting of Stockholders, including election of two Class III directors (Rob Buchner and Sanja Partalo) and ratification of EisnerAmper LLP as independent auditor. The filing presents tabulated vote counts (For, Withheld/Against, Abstained, Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Okta held its Annual Meeting of stockholders on June 18, 2026, with voting results on four proposals: election of two Class III directors (Anthony Bates and David Schellhase), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2017 Equity Incentive Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a clear disclosure of shareholder vote results from AdvanSix's Annual Meeting of Stockholders held on June 22, 2026, covering three matters: election of nine directors, ratification of PricewaterhouseCoopers LLP as independent accountants, and an advisory vote on executive compensation. The filing presents detailed voting tallies (For, Against, Abstain, and Broker Non-Votes) for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures. These outcomes are material to investors as they confirm the composition of the board and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This 8-K Item 5.07 discloses the results of Arlo Technologies' 2026 Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes on three proposals: election of three Class II directors (Grady K. Summers, Prashant Aggarwal, and Amy Rothstein), ratification of Deloitte & Touche LLP as independent auditor, and an advisory vote on named executive officer compensation. The filing presents final vote tallies for each proposal, which is the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 disclosure presents the final voting results from Firy Inc.'s 2026 Annual Meeting of Stockholders held on June 18, 2026, including detailed vote tallies for three proposals: election of eight directors, ratification of Deloitte & Touche LLP as independent auditor, and approval of an amendment to the 2020 Omnibus Incentive Plan. The tabular presentation of votes for, against, abstentions, and broker non-votes is the standard format for shareholder vote result disclosures required by Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-23
Item 5.07
This Item 5.07 filing discloses the final voting results from CXApp's Annual Meeting of stockholders, covering seven proposals including director elections (Khurram P. Sheikh and George Mathai), approval of dilutive equity issuances exceeding 20% of outstanding shares, authorization of a reverse stock split to maintain Nasdaq listing, advisory votes on executive compensation, and auditor ratification. The disclosure is a textbook shareholder vote results filing with detailed vote tallies and outcomes for each matter.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-23
Item 5.07
This Item 5.07 disclosure reports the results of an Extraordinary General Meeting held on June 23, 2026, where shareholders voted on three proposals: an extension amendment to the business combination deadline (from June 19 to October 19, 2026), a corresponding trust agreement amendment, and an adjournment proposal. All three proposals were approved with identical voting tallies (7,459,067 for, 1,980,763 against, 0 abstain). The filing directly states "All three Proposals were approved," which is the core content of a shareholder vote results disclosure under Item 5.07. This is material to investors as it extends the SPAC's deadline to complete its initial business combination and affects the trust account mechanics.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-23
Item 5.07
This Item 5.07 discloses the results of Nuvve's reconvened Special Meeting of Stockholders held on June 23, 2026, where stockholders voted on two substantive proposals: (1) approval of a reverse stock split with a 1-for-2 to 1-for-40 ratio authorized to the Board, and (2) approval of issuance of shares in excess of 19.99% of outstanding shares in connection with the Omnia Venture Agreements. Both proposals passed with substantial majorities. These are material capital structure and financing events requiring shareholder approval under Nasdaq rules.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Grove Collaborative held its 2026 annual meeting on June 18, 2026, with shareholders voting on the election of three Class I directors (Larry Cheng, Stuart Landesberg, and Kristine Miller) and the ratification of Baker Tilly US, LLP as independent auditor, with detailed vote tallies and 76.6% quorum representation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 disclosure presents the final voting results from Core & Main's annual meeting of shareholders held on June 23, 2026, covering three proposals: director elections (Proposal No. 1), ratification of PricewaterhouseCoopers LLP as independent auditor (Proposal No. 2), and advisory approval of named executive officer compensation (Proposal No. 3). The filing explicitly states voting tallies for each matter, which is the defining characteristic of shareholder_vote_results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
STAAR Surgical held its 2026 Annual Meeting of Shareholders and disclosed voting results on four proposals: election of seven directors, approval of Amendment No. 2 to the Amended and Restated Omnibus Equity Incentive Plan (increasing share reserve by 3,900,000 shares), ratification of BDO USA, P.C. as independent auditor, and an advisory vote on executive compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 filing discloses the results of Williams-Sonoma's 2026 Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes for three proposals: election of eight directors (all duly elected), advisory approval of executive compensation, and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies and outcomes are the core disclosure required by Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
Lifetime Brands held its 2026 Annual Meeting of Stockholders on June 22, 2026, with stockholders voting on and approving nine director elections, ratification of Ernst & Young LLP as auditor, advisory approval of named executive officer compensation, and approval of an amended and restated 2000 Long-Term Incentive Plan reserving 10,717,500 shares for future awards.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Titan International's Annual Meeting of Stockholders held on June 18, 2026. The filing presents voting results for three proposals: election of seven directors (all duly elected), ratification of BDO USA P.C. as independent auditor (approved with 51.7M shares for), and non-binding advisory approval of 2025 named executive officer compensation (approved with 45.2M shares for). The detailed vote tallies and high shareholder participation (80.83% of outstanding shares represented) make this a material governance event affecting investor understanding of board composition and auditor selection.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-22
EX-99.1
This press release discloses the results of DHT's 2026 Annual Meeting of Shareholders held on June 18, 2026, including voting outcomes on two matters: (1) election of Jeremy Kramer as a Class I director with 69.93% of votes in favor, and (2) ratification of Ernst & Young AS as independent auditor with 99.86% of votes in favor. The disclosure directly matches the shareholder_vote_results taxonomy entry, which covers results of votes at annual or special meetings of security holders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-22
Item 5.07
Alaska Silver Corp. held its annual and special shareholders meeting on June 19, 2026, with shareholders approving five proposals: setting board size at six directors (99.77%), electing six directors including Christopher Marrs, Nathan Brewer, David Smallhouse, Kevin Nishi, Susan Mitchell, and Aaron Schutt (90.96%–95.49%), re-appointing Davidson & Company LLP as auditors (99.82%), approving the Long Term Incentive Plan (95.21%), and approving issuance of shares to insiders in debt settlement (98.98%), with 30.36% of shares represented at quorum.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
The filing discloses results of an Annual Meeting of Stockholders held on June 17, 2026, with voting outcomes on four proposals: election of three directors, advisory vote on named executive officer compensation, approval of the 2026 Stock and Incentive Compensation Plan, and ratification of Grant Thornton LLP as independent auditor. Item 5.07 explicitly reports these shareholder vote results with detailed vote tallies, making this a classic shareholder_vote_results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
Item 5.07
Shareholders approved a reverse stock split at a ratio of 1-for-2 to 1-for-5 by written consent of Goldeneye, the holder of 92.2% of voting power, in lieu of a special meeting of stockholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 filing discloses the results of MetLife's June 16, 2026 annual shareholder meeting, including election of eleven directors, ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed voting tallies for each director nominee and each proposal are the core content of the disclosure, making this a textbook shareholder vote results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 disclosure reports the results of ArriVent BioPharma's June 18, 2026 annual meeting of stockholders, including the election of three Class II directors (James Healy, John Hohneker, and Stuart Lutzker) and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing provides detailed vote tallies for each matter, which is the core purpose of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
Item 5.07 discloses the final voting results from Cypherpunk Technologies' 2026 Annual Meeting of Stockholders held on June 18, 2026. The section presents tabulated results for three matters: election of Class III directors (Will McEvoy and Nissim Mashiach), advisory approval of executive compensation, and ratification of EisnerAmper LLP as independent auditor. This is a textbook shareholder_vote_results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
CrowdStrike held its Annual Meeting of Stockholders on June 17, 2026, with shareholders voting on four proposals: election of Class I directors (Johanna Flower and Denis J. O'Leary), ratification of PricewaterhouseCoopers LLP as independent auditor, approval of an amendment to limit officer liability under Delaware law, and an advisory vote on supermajority voting provisions. All proposals received shareholder approval with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder voting results from AdaptHealth's June 18, 2026 annual meeting of stockholders. The filing reports the outcomes of three proposals: election of nine directors, ratification of KPMG LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. All three proposals passed with substantial majorities. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and auditor appointment for the fiscal year.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 disclosure reports the results of Terra Property Trust's June 18, 2026 annual stockholder meeting, including the election of all five director nominees and ratification of KPMG LLP as independent auditor. The filing presents detailed voting tallies for each proposal, which is the core content of shareholder vote results disclosures and material to investors assessing board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-06-22
Item 5.07
Holders of Apogee's non-voting common stock executed written consent adopting entry into the Merger Agreement with AbbVie, with consummation remaining subject to affirmative vote of a majority of voting common stock on the $10.9 billion acquisition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Balchem's Annual Meeting of Shareholders held June 18, 2026. The filing reports voting outcomes on three matters: election of two Class 3 directors (David Fischer and Daniel Knutson), ratification of RSM US LLP as independent auditor, and advisory approval of named executive officer compensation. All three votes passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
comScore held its Annual Meeting of Stockholders on June 16, 2026, at which stockholders voted on four proposals: election of two Class I directors (Kline and Wendling), advisory approval of named executive officer compensation, ratification of Deloitte & Touche LLP as independent auditor, and approval of an amendment to the 2018 Equity and Incentive Compensation Plan increasing available shares by 3,000,000. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
Item 5.07
This disclosure reports the results of the 2026 Annual Meeting of Members held on June 16, 2026, where three board managers were elected from three geographical districts with specific voting tallies provided for each candidate. The filing directly corresponds to Item 5.07 (Submission of Matters to Vote of Security Holders) and presents the outcome of shareholder/member votes on director elections, which is material to investors' understanding of corporate governance and board composition.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-22
The 6-K discloses results of an annual general meeting of shareholders held on June 18, 2026, at which three proposals were voted on and all were approved by the requisite shareholder vote. This is a direct disclosure of shareholder vote results, matching the definition of shareholder_vote_results (Item 5.07 equivalent). The materiality is high because shareholder votes on proposals at annual meetings are material governance events affecting the registrant's direction and capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Codexis's 2026 Annual Meeting held on June 17, 2026. The filing reports final voting tallies on three proposals: election of three directors (Stephen G. Dilly, Raymond De Vré, and Rahul Singhvi), ratification of KPMG LLP as independent auditor, and advisory approval of executive compensation. The disclosure includes vote counts (For, Against, Withheld, Abstain, Broker Non-Votes) for each proposal, certified by the Inspector of Elections.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
EyePoint held its Annual Meeting on April 21, 2026, with stockholders voting on four proposals: election of eight directors (all passed with substantial majorities), amendment to the 2023 Long-Term Incentive Plan to increase authorized shares by 4,900,000 (approved), non-binding advisory vote on named executive officer compensation (approved), and ratification of Deloitte & Touche LLP as independent auditor (approved with 99.4% support).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
Item 5.07
Revolution Medicines held its annual stockholder meeting on June 18, 2026, with shareholders voting on the election of two Class III directors (Alexis Borisy and Mark A. Goldsmith, M.D., Ph.D.), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting held on June 18, 2026, covering three matters: election of 11 directors, advisory vote on named executive officer compensation, and ratification of KPMG LLP as independent auditor. The filing directly corresponds to Item 5.07 and presents the vote tallies for each proposal, making this a textbook shareholder_vote_results event that is material to investors assessing corporate governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
Oric Pharmaceuticals held its annual meeting of stockholders on June 18, 2026, with voting results on five proposals: election of Class III directors (Jacob M. Chacko and Mardi C. Dier), ratification of KPMG LLP as independent auditor, approval of the amended 2020 Equity Incentive Plan, advisory approval of named executive officer compensation, and advisory vote on frequency of future compensation votes. All proposals passed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
BridgeBio held its Annual Meeting of Stockholders on June 16, 2026, at which shareholders voted on the election of two Class I directors (Peter Lebowitz and Frank P. McCormick) and the ratification of Deloitte & Touche LLP as independent auditor, with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder vote results from the Company's 2026 Annual Meeting of Stockholders held on June 17, 2026. The filing reports voting outcomes for three proposals: election of Class III directors (Proposal 1), ratification of PricewaterhouseCoopers LLP as independent auditor (Proposal 2), and advisory approval of named executive officer compensation (Proposal 3), with detailed vote tallies for each. This is a standard Item 5.07 disclosure and is material as it reflects stockholder approval of governance and compensation matters.
View raw filing on EDGAR →